Investigators in the Smidt Heart Institute at Cedars-Sinai and colleagues report that women with type 2 diabetes diagnosed with hypertension before age 50 may benefit from intensive blood pressure treatment.
Apr 25, 2024
0
34
Physical activity in natural environments prevent almost 13,000 cases of non-communicable diseases a year in England and save treatment costs of more than £100m, new research from the University of Exeter has found.
Apr 25, 2024
0
0
Millions of people around the world live with diabetes mellitus. Many of them have medication and specific dietary management approaches to help them maintain stable blood sugar levels. However, recent innovations, such as ...
Apr 25, 2024
0
29
Survivors of childhood cancer are at increased risk for cardiovascular disease, for which a risk factor is their greater prevalence of type 2 diabetes, with a disproportionate impact on those of non-European heritage. St. ...
Apr 24, 2024
0
24
A study by researchers from Karl Landsteiner University of Health Sciences (KL Krems) highlights the urgent need for improved care and information for women with hypertensive disorders of pregnancy or gestational diabetes.
Apr 16, 2024
0
0
Rutgers Health researchers have found that hypertensive disorders in pregnancy are strongly associated with fatal cardiovascular disease for up to a year after birth.
Apr 11, 2024
0
1
Combining a low dose of blood pressure medication with a higher intake of dietary-resistant starch might help stave off diabetic kidney disease, according to results from a new animal study. Kidney disease is a common diabetes ...
Apr 10, 2024
0
18
Nearly four in every 1,000 U.S. youths and five in every 1,000 U.S. adults reported having type 1 diabetes from 2019 through 2022, according to a research letter published online April 4 in the Journal of the American Medical ...
Apr 10, 2024
0
1
One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes did not meet its primary endpoint, but a preplanned subgroup analysis found a statistically significant effect of treatment ...
Apr 8, 2024
0
18
A new meta-analysis shows sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular events in patients with either diabetes at high risk of atherosclerotic cardiovascular disease (ASCVD), ...
Apr 8, 2024
0
0
